What are the thrombolytic regimens for reteplase in patients with deep vein thrombosis (DVT)?

Updated: Dec 31, 2017
  • Author: Wanda L Rivera-Bou, MD, FAAEM, FACEP; Chief Editor: Erik D Schraga, MD  more...
  • Print
Answer

Answer

Reteplase is not approved by the US Food and Drug Administration (FDA) for lysis of venous thrombus in DVT but is often used off label. Catheter-directed infusion of 1 U/hr is maintained for 18-36 hours.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!